Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.
Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.

The global Intravenous (IV) Solutions market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intravenous (IV) Solutions volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Solutions market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Intravenous (IV) Solutions in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Intravenous (IV) Solutions manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ICU Medical Inc. (US)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (US)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Segment by Application
Hospital & Clinics
Ambulatory
Home Care